Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Flu in a post-COVID world: Learnings from SHIVERS-V

This article presents some major themes from research into the impact of the COVID-19 pandemic on other viral respiratory illnesses
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Huang QS, Turner N, Wood T, et al. Impact of the COVID-19 related border restrictions on influenza and other common respiratory viral infections in New Zealand. Influenza Other Respir Viruses 2024;18(2):e13247.
2. Turner N, Aminisani N, Huang S, et al. Comparison of the burden and temporal pattern of hospitalisations associated with respiratory syncytial virus (RSV) before and after COVID-19 in New Zealand. Influenza Other Respir Viruses 2024;18(7):e13346.
3. ESR. Respiratory Illness Dashboard.
4. Dowell A, Huang S, McIntosh C, et al. Towards new forms of communication and surveillance: a mixed methods study of rapid respiratory virus assessment in general practice during the SARS-CoV-2 pandemic. J Prim Health Care 2024;16 July online.